# Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis

> **NCT02763111** · PHASE2 · COMPLETED · sponsor: **Biocad** · enrollment: 88 (actual)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

- **DRUG:** BCD-085
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02763111
- **Lead sponsor:** Biocad
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2021-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02763111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02763111, "Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02763111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*